Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial

CH Lin, PK Chen, YC Chang, LJ Chuo, YS Chen… - Biological …, 2014 - Elsevier
N-methyl-D-aspartate receptor (NMDAR)-mediated … D-cycloserine, a partial agonist at the
glycine site of NMDAR, was reported in some clinical studies to activate the NMDAR in brains

The glutamatergic system and Alzheimer's disease: therapeutic implications

DA Butterfield, CB Pocernich - CNS drugs, 2003 - Springer
… receptor with glycine and cycloserine (D-cycloserine). Recently, … to accumulate in the brains
of individuals with Alzheimer’s … NMDA receptor activation and neuronal injury in brain areas …

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

JH Krystal, DC D'Souza, IL Petrakis… - Harvard review of …, 1999 - Taylor & Francis
… partial agonist D-cycloserine gained interest as a nootropic agent … In humans with Alzheimer’s
disease, D-cycloserine … the N-methyl-D-aspartate receptorionophore complex in human …

Memory impairment in rats with glutamatergic temporal systems disrupted is attenuated by D-cycloserine: Effects of postoperative time of injection

T Myhrer, RE Paulsen - Psychobiology, 1995 - Springer
Alzheimer patients, D-cycloserine facilitates activation of the NMDA receptor-ionophore
complex (… activation ofthe N-methyl-o-aspartate receptor-ionophore complex in Alzheimer brain. …

[图书][B] Biochemical and anatomical correlates of cortical pyramidal neurones-Implications for the treatment of Alzheimer's disease

IP Chessell - 1994 - search.proquest.com
… of a putative partial agonist, D-cycloserine, at the glycine modulatory site of the N-methyl-D-aspartate
receptor-ionophore complex (… prepared from Alzheimer's brains, D-cycloserine was …

The stereo-specific effect of D-serine ethylester and the D-cycloserine in ataxic mutant mice

K Saigoh, K Matsui, K Takahashi, T Nishikawa, K Wada - Brain research, 1998 - Elsevier
… , d-cycloserine, as therapeutic agents for ataxia in a murine model. Both compounds are known
to stereospecific modulate N-methyl-d-aspartate … disturbance in Alzheimer's patients 2, 27…

Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders

P Chakraborty, A Dey, AV Gopalakrishnan… - Ageing Research …, 2023 - Elsevier
… formulate a complex glutamatergic network in the brain that … The iGluRs include N-methyl-D-aspartate
(NMDA), α-amino-3… the NMDA ion channel pore and facilitate the passage of Ca 2 …

Targeted treatment of individuals with psychosis carrying a copy number variant containing a genomic triplication of the glycine decarboxylase gene

JA Bodkin, MJ Coleman, LJ Godfrey, CMB Carvalho… - Biological …, 2019 - Elsevier
N-methyl-D-aspartate receptor augmentation of psychotropic drug treatment in these two
individuals. Glycine was used in the first clinical trial, and D-cycloserine … levels of brain glycine …

Behavioral effects of d-cycloserine in rats: the role of anxiety level

YJ Ho, LS Hsu, CF Wang, WY Hsu, TJ Lai, CC Hsu… - Brain research, 2005 - Elsevier
… reported that the glutamatergic N-methyl-d-aspartate (NMDA) … respond differently to treatment
with d-cycloserine (DCS), a … and is required for receptor activation by glutamate [16], [22]. …

Effects of D-cycloserine on negative symptoms in schizophrenia

EJ Duncan, S Szilagyi, MP Schwartz… - Schizophrenia …, 2004 - Elsevier
N-methyl-d-aspartate (NMDA) glutamate receptor, such as phencyclidine and ketamine,
produce cognitive … abnormalities of glutamate receptors in brains of patients with schizophrenia, …